Showing results (41-50 of 431) with videos related to
Sort By:
Pageof 44
The Oncologist|June 24, 2006
Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancerN Lynn Henry, Daniel F HayesJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Publication of tumor marker research results: the necessity for complete and transparent reportingLisa M McShane, Daniel F HayesArchives of Internal Medicine|June 16, 2005
Undertreatment of obese women receiving breast cancer chemotherapyJennifer J Griggs, Melony E S Sorbero, Gary H LymanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2018
Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral NeuropathyDaniel L Hertz, Kelley M Kidwell, Kiran Vangipuram, et al.Breast Cancer Research : BCR|September 7, 2006
Recent translational research: circulating tumor cells in breast cancer patientsVolkmar Müller, Daniel F Hayes, Klaus PantelJournal of Oncology Practice|January 4, 2011
American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancerHarold J Burstein, Jennifer J Griggs, Ann A Prestrud, et al.Breast (Edinburgh, Scotland)|August 21, 2007
Angiogenesis as targeted breast cancer therapyDaniel F Hayes, Kathy Miller, George SledgeGynecologic Oncology|August 6, 2010
Casting light on 25-hydroxyvitamin D deficiency in ovarian cancer: a study from the NHANESArvind Bakhru, Julie B Mallinger, Ronald J Buckanovich, et al.Journal of Cancer Survivorship : Research and Practice|November 13, 2008
Hot flashes, fatigue, treatment exposures and work productivity in breast cancer survivorsJill E Lavigne, Jennifer J Griggs, Xin M Tu, et al.Cancer|July 11, 2013
Marginal treatment benefit in anaplastic thyroid cancerMegan R Haymart, Mousumi Banerjee, Huiying Yin, et al.Pageof 44